Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeX Group specializes in contamination control for critical environments across biotech, hospital pharmacy, medtech, industrial pharmacy, medically assisted reproduction (IVF-PMA), and related sectors. It offers services including environmental qualification/testing (HeX Testing), audits/training (HeX Consult), calibration of probes/sensors (HeX Cal), and microbiological analyses/validation of decontamination processes (HeX Lab). The company operates under ISO 17025/17020 standards and holds GMP certification for quality control of drug products. It has developed proprietary solutions such as the Lyra data acquisition system.
No clinical results or therapeutic pipeline exist as it does not develop drugs or therapies.
The group has a strong reputation in Europe for expertise in cleanroom validation, metrology, microbiology testing, equipment qualification/certification—including biosafety cabinet testing—and compliance with regulatory requirements such as GMP and FDA’s 21 CFR Part 11.
It serves hundreds of customer sites with a pragmatic approach focused on expertise and quality.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeX Group.